⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Sulfuric Acid Dimethyl Ester SCHEMBL1249 | 0.95 | — | — | |
| Sulfuric Acid Dimethyl Ester SCHEMBL28170913 | 0.95 | USP2 (0.54) | — | |
| Sulfuric Acid Dimethyl Ester SCHEMBL10001069 | 0.95 | — | — | |
| Sulfuric Acid Dimethyl Ester SCHEMBL5793368 | 0.91 | — | — | |
| Sulfuric Acid Dimethyl Ester SCHEMBL18989633 | 0.91 | — | — | |
| Sulfuric Acid Dimethyl Ester SCHEMBL23174832 | 0.91 | — | — | |
| Sulfuric Acid Dimethyl Ester SCHEMBL1030909 | 0.91 | — | — | |
| Sulfuric Acid Dimethyl Ester SCHEMBL4280887 | 0.91 | — | — | |
| Sulfuric Acid Dimethyl Ester SCHEMBL5177964 | 0.91 | — | — | |
| Sulfuric Acid Dimethyl Ester SCHEMBL11129814 | 0.91 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1643993-A2 | SUBSTITUTED ISOCHROMAN COMPOUNDS FOR THE TREATMENT OF METABOLIC DISORDERS, CANCER AND OTHER DISEASES | Incyte San Diego Incorporated (US) | 2006-04-12 | — | — | EP | disclosed |
| US-20050038098-A1 | Substituted dihydronaphthalene and isochroman compounds for the treatment of metabolic disorders, cancer and other diseases | INCYTE CORPORATION | 2005-02-17 | — | — | US | disclosed |
| WO-2004093809-A2 | SUBSTITUTED ISOCHROMAN COMPOUNDS FOR THE TREATMENT OF METABOLIC DISORDERS, CANCER AND OTHER DISEASES | INCYTE SAN DIEGO INCORPORATED (US) | 2004-11-04 | — | — | WO | disclosed |